Utility of Antiphosphatidylserine/Prothrombin and IgA Antiphospholipid Assays in Systemic Lupus Erythematosus
Open Access
- 1 February 2013
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 40 (3), 282-286
- https://doi.org/10.3899/jrheum.120084
Abstract
Objective.: Currently, 3 antiphospholipid assays are widely used clinically [lupus anticoagulant (LAC), anticardiolipin (aCL), and anti-ß2-glycoprotein I (anti-ß2-GPI)]. LAC is the most specific assay, conferring the highest risk of thrombosis and pregnancy loss, but it cannot be validly performed in an anticoagulated patient. We investigated the usefulness of antiphosphatidylserine/prothrombin (anti-PS/PT) and its association with thrombosis. Anti-PS/PT is strongly associated with the presence of LAC. We also studied the association of IgA antiphospholipid isotypes and specific domains of ß2-GPI with thrombosis in systemic lupus erythematosus (SLE).Methods.: Stored samples from patients with SLE, with and without past thrombosis, were assayed for antibodies to the whole ß2-GPI protein (IgG/IgM/IgA), to ß2-GPI domain 1 (IgG), to ß2-GPI domain 4/5 (IgA), aCL (IgG/IgM/IgA), and anti-PS/PT (IgG, IgM, and IgG/M). LAC was detected using the dilute Russell’s viper venom time (dRVVT) with confirmatory testing.Results.: Anti-PS/PT IgG and IgG/M and anti-ß2-GPI IgG, IgM, and IgA were highly associated with a history of LAC by dRVVT (p < 0.0001). For all thrombosis, of the traditional ELISA assays, anti-ß2-GPI IgA, IgG, and aCL IgA were most associated. Anti-PS/PT IgG and IgG/M had a similar magnitude of association to the traditional ELISA. For venous thrombosis, of the traditional ELISA, anti-ß2-GPI (IgG and IgA), anti-PS/PT (IgG and IgG/M), and aCL IgA were associated. Again, anti-PS/PT (IgG and IgG/M) had the same magnitude of association as the traditional ELISA. For stroke, significant association was seen with anti-ß2-GPI IgA D4/5.Conclusion.: In anticoagulated patients, where LAC testing is not valid, anti-PS/PT, either IgG or IgG/IgM, might serve as useful alternative tests to predict a higher risk of thrombosis. Anti-PS/PT antibodies were associated with all thrombosis and with venous thrombosis. IgA isotypes in secondary antiphospholipid syndrome are associated with thrombosis. Anti-ß2-glycoprotein domain 1 was not shown to be associated with thrombosis in SLE.This publication has 32 references indexed in Scilit:
- Association of IgA Anti-ß2 Glycoprotein I with Clinical and Laboratory Manifestations of Systemic Lupus ErythematosusThe Journal of Rheumatology, 2010
- Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine–prothrombin complex: Identical or distinct diagnostic tools for antiphospholipid syndrome?Clinica Chimica Acta; International Journal of Clinical Chemistry, 2009
- The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter studyJournal of Thrombosis and Haemostasis, 2009
- Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of β2-GPIJournal of Autoimmunity, 2006
- Clinical significance of IgA anticardiolipin and anti-β2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndromeClinical Rheumatology, 2006
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Antiprothrombin antibodies detected in two different assay systemsThrombosis and Haemostasis, 2005
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Antibodies to Phospholipid-Binding Plasma Proteins and Occurrence of Thrombosis in Patients with Systemic Lupus ErythematosusClinical Immunology and Immunopathology, 1996
- PHOSPHATTDYL SERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODY IS EXCLUSIVE TO PATIENTS WITH LUPUS ANTICOAGULANTRheumatology, 1996